Physician profile
John A Drkulec
NPI 1326013897
$4,229.24
in general payments reported to CMS, 2019-2025
18 companies · $629 in 2025
The $629 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $818 · 2020: $1,756 · 2021: $133 · 2022: $491 · 2023: $115 · 2024: $287 · 2025: $629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,031.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,030.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,227.21 | 2020 | |
| Smith+Nephew, INC. | $612.77 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Biosure, Acufex Meniscal Root Repair |
| Pylant Medical | $519.47 | 2020-2025 | |
| Pacira Therapeutics, INC. | $347.75 | 2019-2021 | |
| Stryker Corporation | $222.55 | 2019-2023 | Inspace |
| Vericel Corporation | $212.73 | 2019-2022 | |
| Myoscience INC. | $206.59 | 2019 | |
| Ferring Pharmaceuticals INC. | $156.66 | 2019-2025 | Euflexxa |
| Zimmer Biomet Holdings, INC. | $134.32 | 2022 | |
| Depuy Synthes Sales INC. | $122.84 | 2019-2024 | Monovisc |
| Vertex Pharmaceuticals Incorporated | $121.91 | 2025 | |
| Horizon Therapeutics Plc | $116.18 | 2019-2021 | |
| Linvatec Corporation | $108.03 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $39.48 | 2022-2025 | Zilretta, Iovera |
| Bioventus LLC | $32.42 | 2025 | Exogen Ultrasound Bone Healing System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $21.49 | 2019 | |
| Curonix LLC | $15.79 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Fidia Pharma USA INC. | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Drkulec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.